Antiviral Agents ; therapeutic use ; DNA, Viral ; blood ; Hepatitis B ; immunology ; therapy ; Hepatitis B e Antigens ; blood ; Hepatitis B virus ; immunology ; Humans ; Immunotherapy

Interferons ; Liver Diseases

Humans ; Liver Cirrhosis ; therapy

Antiviral Agents ; therapeutic use ; Hepatitis B ; drug therapy ; Humans ; Prospective Studies

Objective To test the utility of a new type of inflatable rehabilitation boot in the treatment of Danis-Weber type-A stable external malleolus fractures. Methods Fifty-four patients with stable external malleolus fractures were randomized into two groups. After closed reduction, the observation group was treated by immobilisation with the inflatable rehabilitation boot and the control group with a plaster slab. All were instructed to avoid weight-bearing on the affected side. The swelling volume of the injured limb was measured by drainage measurement before treatment and at the 1st, 3rd and 7th days after treatment. Pain was evaluated using a visual analogue scale (VAS) score before treatment and after 12, 24 and 72 hours. All of the ankles were x-rayed to recheck for displacement after 2weeks. Results The average volume of the injured limbs in the observation group was significantly less than in the control group at every time point. The average VAS score in the observation group was significantly lower than that in the control group. Fracture displacement in the observation group was also significantly better. Conclusions The inflatable rehabilitation boot has better curative efficacy than the typical plaster slab for patients with stable external malleolus fractures in terms of improving edema in the injured limb, relieving pain and preventing fracture displacement.

Abdominal Neoplasms ; diagnosis ; secondary ; Adult ; Animals ; Female ; Humans ; Liver Diseases, Parasitic ; diagnosis ; Liver Neoplasms ; diagnosis ; parasitology ; pathology ; Neoplasm Metastasis ; Paragonimiasis ; diagnosis

Adenine ; analogs & derivatives ; therapeutic use ; Animals ; Antiviral Agents ; therapeutic use ; Combined Modality Therapy ; Genetic Therapy ; Hepatitis B Antigens ; immunology ; Hepatitis B Vaccines ; therapeutic use ; Hepatitis B, Chronic ; therapy ; Humans ; Interferon-alpha ; administration & dosage ; Lamivudine ; therapeutic use ; Organophosphonates ; therapeutic use ; Recombinant Proteins

Humans ; Liver Failure

Antihypertensive Agents ; therapeutic use ; Blood Pressure ; Humans ; Hypertension ; therapy

Antiviral Agents ; therapeutic use ; Hepatitis B ; drug therapy ; Hepatitis C ; drug therapy ; Humans ; Interferons ; therapeutic use